ORIGINAL RESEARCH PAPER
Figure from article: The effects of turmeric,...
 
KEYWORDS
TOPICS
ABSTRACT
Dyslipidemia is a major independent risk factor for cardiovascular disease and requires effective management strategies, including dietary modification and the use of medicinal plants. This study aimed to evaluate the effects of turmeric ethanol extract, strawberry juice, and broccoli juice on lipid profile parameters and hepatic histopathology in male Wistar rats with high-fat diet–induced dyslipidemia. Fifteen male Wistar rats aged 6–8 weeks were randomly divided into five groups: negative control receiving standard feed, positive control receiving a high-fat diet, and three treatment groups receiving turmeric ethanol extract, strawberry juice, or broccoli juice. The high-fat diet (60 g/cage/day) was administered for 11 weeks, followed by four weeks of treatment with turmeric ethanol extract (270 mg/kg body weight/day), strawberry juice (9 g/kg body weight/day), or broccoli juice (9 g/kg body weight/day). Administration of turmeric ethanol extract and strawberry juice significantly reduced total cholesterol, low-density lipoprotein, and triglyceride levels, whereas broccoli juice reduced low-density lipoprotein and triglyceride levels without significantly affecting total cholesterol. Histopathological examination of liver tissue demonstrated that turmeric ethanol extract and broccoli juice exerted protective effects against hepatic steatosis and hepatocellular necrosis, while strawberry juice showed no significant hepatoprotective effect. These findings indicate that turmeric ethanol extract and broccoli juice possess both hypolipidemic and hepatoprotective properties, whereas strawberry juice primarily exhibits hypolipidemic activity in male Wistar rats with high-fat diet–induced dyslipidemia.
REFERENCES (22)
1.
Akram, M., Khan I., Mehar, P., Hussain, A., Ali, A.A., Ayaz, P.S., Ali, A. et al. 2021. “Hepatoprotective Effects of Various Medicinal Plants: A Systematic Review.” Journal of Pharmacognosy and Phytochemistry 10(3): 109–21. www.phytojournal.com.
 
2.
Alloubani, A., Nimer, R. and Samara, R., 2020. “Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review.” Current Cardiology Reviews 17(6). https://doi.org/10.2174/157340....
 
3.
Berisha, H., Hattab, R., Comi, L., Giglione, C., Migliaccio, S. and Magni, P., 2025. “Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk.” Nutrients 17(5): 1–13. https://doi.org/10.3390/nu1705....
 
4.
Buonomo, Riccardo, A., Scotto, R., Nappa, S., Arcopinto, M., Salzano, A., Marra, A.M., D’Assante, R., et al., 2019. “The Role of Curcumin in Liver Diseases.” Archives of Medical Science 15(6): 1608–20. https://doi.org/10.5114/aoms.2....
 
5.
Chen, C.Y., Lee, C.W., Chien, S.C., Su, M.I., Lin, S.I., Cheng, C.W., Hung, T.C. and Yeh, H.I., 2018. “Dyslipidemia Management for Elderly People with Metabolic Syndrome: A Mini-Review.” International Journal of Gerontology 12(1): 7–11. https://doi.org/10.1016/j.ijge....
 
6.
Du, Z., and Qin, Y., 2023. “Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies.” Journal of Clinical Medicine 12(1): 12–15. https://doi.org/10.3390/jcm120....
 
7.
Forbes-Hernández, T.Y., Giampieri, F., Gasparrini, M., Afrin, S., Mazzoni, L., Cordero, M.D., Mezzetti, B., Quiles, J.L., and Battino, M. 2017. “Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation.” Nutrients 9(6): 1–19. https://doi.org/10.3390/nu9060....
 
8.
Houghton, C.A., Fassett, R.G., and Coombes, J.S., 2016. “Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician’s Expectation Be Matched by the Reality?” Oxidative Medicine and Cellular Longevity 2016. https://doi.org/10.1155/2016/7....
 
9.
Klop, B., Elte, J.W.R., and Cabezas, M.C., 2013. “Dyslipidemia in Obesity: Mechanisms and PotentialTargets.” Nutrients 5(4): 1218–40. https://doi.org/10.3390/nu5041....
 
10.
Kosmas, C.E., Polanco, S.R., Bousvarou, M.D., Papakonstantinou, E.J., Genao, E.P., Guzman, E. and Kostara, C.E., 2023. “The Triglyceride/ High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease.” Diagnostics 13(5). https://doi.org/10.3390/diagno....
 
11.
Lința, A.V., Lolescu, B.M., Ilie, C.A., Vlad, M., Blidișel, A., Sturza, A., Borza, C., Muntean, D.M., and Crețu, O.M., 2024. “Liver and Pancreatic Toxicity of Endocrine-Disruptive Chemicals: Focus on Mitochondrial Dysfunction and Oxidative Stress.” International Journal of Molecular Sciences 25(13). https://doi.org/10.3390/ijms25....
 
12.
Lu, Y., Cui, X., Zhang, L., Wang, X., Xu, Y., Qin, Z., Liu, G., et al. 2022. “The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy.” Aging and Disease 13(2): 491–520. https://doi.org/10.14336/AD.20....
 
13.
Mallhi, I.Y., Sohaib, M., Khan, A.U., and Rabbani, I., 2023. “Antidiabetic, Antioxidative and Antihyperlipidemic Effects of Strawberry Fruit Extract in Alloxan-Induced Diabetic Rats.” Foods 12(15): 1–11. https://doi.org/10.3390/foods1....
 
14.
Martin, A., Lang, S., Goeser, T., Demir, M., Steffen, H.M., and Kasper, P., 2022. “Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease.” Current Atherosclerosis Reports 24(7): 533–46. https://doi.org/10.1007/s11883....
 
15.
Mohamed-Yassin, M.S., Baharudin, N., Abdul-Razak, S., Ramli, A.S., and Lai, N.M., 2021. “Global Prevalence of Dyslipidaemia in Adult Populations: A Systematic Review Protocol.” BMJ Open 11(12): 9–12. https://doi.org/10.1136/bmjope....
 
16.
Peng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C., and Xu, R., 2021. “Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures.” Drug Design, Development and Therapy 15: 4503–25. https://doi.org/10.2147/DDDT.S....
 
17.
de Porras, V.R., Figols, M., Font, A., and Pardina, E., 2023. “Curcumin as a Hepatoprotective Agent against Chemotherapy-Induced Liver Injury.” Life Sciences 332(August): 122119. https://doi.org/10.1016/j.lfs.....
 
18.
Ruscica, M., Ferri, N., Banach, M., Sirtori, C.R., and Corsini, A., 2022. “Side Effects of Statins: From Pathophysiology and Epidemiology to Diagnostic and Therapeutic Implications.” Cardiovascular Research 118(17): 3288–3304. https://doi.org/10.1093/cvr/cv....
 
19.
Służały, P., Paśko, P., and Galanty, A., 2024. “Natural Products as Hepatoprotective Agents—A Comprehensive Review of Clinical Trials.” Plants 13(14). https://doi.org/10.3390/plants....
 
20.
Sotelo-González, A.M., Reynoso-Camacho, R., Hernández-Calvillo, A.K., Castañón-Servín, A.P., García-Gutiérrez, D.G., de Jesús Gómez-Velázquez, H.K., Martínez-Maldonado, M.Á. de los Ríos, E.A., and Pérez-Ramírez, I.F., 2023. “Strawberry, Blueberry, and Strawberry-Blueberry Blend Beverages Prevent Hepatic Steatosis in Obese Rats by Modulating Key Genes Involved in Lipid Metabolism.” International Journal of Environmental Research and Public Health 20(5): 1–21. https://doi.org/10.3390/ ijerph20054418.
 
21.
Thomes, P.G., Rensch, G., Casey, C.A., and Donohue, T.M., 2023. “Ethanol Exposure to Ethanol-Oxidizing HEPG2 Cells Induces Intracellular Protein Aggregation.” Cells 12(7): 1–10. https://doi.org/10.3390/cells1....
 
22.
Wazir, M., Olanrewaju, O.A., Yahya, M., Kumari, J., Kumar, N., Singh, J., Al-itbi, A.Y.A., et al. 2023. “Lipid Disorders and Cardiovascular Risk: A Comprehensive Analysis of Current Perspectives.” Cureus 15(12): 1–12. https://doi.org/10.7759/cureus....
 
eISSN:2583-1194
Journals System - logo
Scroll to top